eagle-i Jackson State UniversityJackson State University
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Dyslipidemia and the treatment of lipid disorders in African Americans.

eagle-i ID

http://jsu.eagle-i.net/i/0000012e-0c55-1d1d-d3a1-177580000000

Resource Type

  1. Epidemiological study

Properties

  1. Additional Topic(s)
    Hypolipidemic Agents
  2. Resource Description
    Abstract BACKGROUND: Despite the high prevalence of cardiovascular disease documented among the African-American population, there has been little emphasis on the role of dyslipidemia as a prominent risk factor in this large subpopulation. Questions of medication efficacy also have been raised. Together, these factors may have affected awareness, diagnosis, and treatment rates. METHODS AND RESULTS: Dyslipidemia was defined as the presence of either hypercholesterolemia or hypertriglyceridemia using National Cholesterol Education Program III criteria and the fasting lipid measurements, self-reported treatment history, and medication survey available from 5302 Jackson Heart Study participants. Dyslipidemia was more common in men (compared with women) aged less than 50 years and increased with age in both genders. Hypercholesterolemia prevalence rates approached 50% in women aged more than 65 years. The lifestyle-related attributes found to be related to prevalence were being overweight and less physically active, and all disease status variables exhibited significant (P<.05) associations. Awareness of hypercholesterolemia is approximately 55% or more in both men and women aged more than 35 years. Treatment rates lag far behind awareness, particularly in younger adult men, and less than 50% of women and men aged less than 65 years were treated for hypercholesterolemia. CONCLUSION: Higher rates of identification and effective treatment of dyslipidemia are clearly needed in this, and probably other African-American communities. Despite the less than optimal treatment, the identification and importance of the known cardiovascular disease states and risk factors in these analyses suggest the adoption of National Cholesterol Education Program III "high-risk strategy" algorithms in treatment recommendations and decisions by providers is occurring.
  3. Contact
    Taylor, Jr., Herman A.
  4. PI
    Taylor, Jr., Herman A.
  5. Topic
    lipid metabolism disorder
  6. Study Population
    5,302 Jackson Heart Study participants
  7. Related Publication or Documentation
    Dyslipidemia and the treatment of lipid disorders in African Americans.
  8. Funded by
    National Center for Minority Health and Health Disparities
  9. Funded by
    National Heart, Lung, and Blood Institute
  10. Performed by
    Jackson Heart Study
 
RDFRDF
 
Provenance Metadata About This Resource Record
  1. workflow state
    Published
  2. contributor
    nvasilevsky
  3. created
    2011-02-09T15:33:23.182-06:00
  4. creator
    sgarner (Solomon Garner)
  5. modified
    2011-05-18T13:03:05.273-05:00

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016